Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

HTSeq—a Python framework to work with high-throughput sequencing data

Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068

Metagenomic biomarker discovery and explanation

Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192

GSVA: gene set variation analysis for microarray and RNA-Seq data

Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668

Cancer statistics, 2013

Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825

Cancer statistics, 2009

Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709

The resurgence of platinum-based cancer chemotherapy

Kèlland, L. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2167 · Cited by 4,733

Combinatorial microRNA target predictions

Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603

Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes

Gaiani, F., Marchesi, F., Negri, F., Greco, L., Malesci, A., de’Angelis, G. L., & Laghi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105246 · Cited by 24

The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer

Ying, H., Sun, F., Liao, Y., Cai, D., Yang, Y., & Cheng, X. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211022886 · Cited by 23

Nanotechnological interventions of the microbiome as a next-generation antimicrobial therapy

Trivedi, R., Upadhyay, T. K., Kausar, M. A., Saeed, A., Sharangi, A. B., Almatroudi, A., Alabdallah, N. M., Saeed, M., & Aqil, F. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155085 · Cited by 24

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer

AL-Ishaq, R. K., Koklesová, L., Kubatka, P., & Büsselberg, D. (2022) · Cancers · doi:10.3390/cancers14092140 · Cited by 23

Implications of Gut Microbiota in Epithelial–Mesenchymal Transition and Cancer Progression: A Concise Review

Gupta, I., Pedersen, S., Vranić, S., & Moustafa, A. A. (2022) · Cancers · doi:10.3390/cancers14122964 · Cited by 25

Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR / CYP1A1 signalling

Yin, H., Zhang, J., Zhang, H., Li, Q., Qiu, H., Hong, K., Wang, W., Xiao, Y., & Yu, B. (2022) · FEBS Journal · doi:10.1111/febs.16619 · Cited by 27

Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out

Conti, G., D’Amico, F., Fabbrini, M., Brigidi, P., Barone, M., & Turroni, S. (2022) · Genes · doi:10.3390/genes14010055 · Cited by 25

A tumor-associated bacteria-responsive magnetic exosome as a clearable T1 contrast agent for targeted imaging of tumors

Wei, X., Mu, D., Li, Y., Zhao, J., & Zhou, S. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101796 · Cited by 23

Connecting the dots in the associations between diet, obesity, cancer, and microRNAs

Otsuka, K., Nishiyama, H., Kuriki, D., Kawada, N., & Ochiya, T. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.05.001 · Cited by 26

Association between oral microbiome and seven types of cancers in East Asian population: a two-sample Mendelian randomization analysis

Feng, K., Ren, F., & Wang, X. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1327893 · Cited by 24

H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer

Chowdhury, P. R., Salvamani, S., Gunasekaran, B., Hoh, B., & Ulaganathan, V. (2023) · The Yale Journal of Biology and Medicine · doi:10.59249/tdbj7410 · Cited by 26

Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy

Zhang, J., Wang, P., Wang, J., Wei, X., & Wang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107185 · Cited by 25

Oral hygiene might prevent cancer

Cordero, O. J., & Varela‐Calviño, R. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00879 · Cited by 25

Hyaluronic acid/PEGylated amphiphilic nanoparticles for pursuit of selective intracellular doxorubicin release

Yan, X., Chen, Q., An, J., Liu, D., Huang, Y., Yang, R., Li, W., Chen, L., & Gao, H. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02370k · Cited by 24

The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients

Mihai, M. M., Ion, A., Giurcăneanu, C., Niţipir, C., Popa, A. M., Chifiriuc, M. C., Popa, M. I., Říčař, J., Popa, L. G., Sârbu, I., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153219 · Cited by 24

Blocking Fusobacterium nucleatum-host cell interactions with responsive supramolecular GalNAc-derived nanoplatform for enhanced chemotherapy in colorectal cancer

Wu, T., Jin, D., Wu, M., Xin, Y., Liu, H., Li, N., Ma, F., Yu, Y., Wang, B., Zhao, J., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102288 · Cited by 22

Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy

Qian, J., Zhao, L., Xu, L., Zhao, J. X., Tang, Y., Yu, M., Lin, J., Ding, L., & Cui, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179703 · Cited by 23

Parvimonas micra promotes oral squamous cell carcinoma metastasis through TmpC-CKAP4 axis

Qi, H., Gao, H., Li, M., Sun, T., Gu, X., Wei, L., Zhi, M., Li, Z., Fu, D., Liu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57530-1 · Cited by 25

Cancer microbiota: a focus on tumor-resident bacteria

Vella, G., & Rescigno, M. (2025) · EMBO Reports · doi:10.1038/s44319-025-00482-w · Cited by 25

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway

Chen, Y. X., Qin, Y., Dai, M., Liu, L., Ni, Y., Sun, Q., Li, L., Zhou, Y., Qiu, C., & Jiang, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.3959 · Cited by 22

Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro

Chen, Z., Liu, S., Xie, P., Zhang, B., Yu, M., Yan, J., Jin, L., Zhang, W., Zhou, B., Li, X., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.075 · Cited by 22

Patients with Primary and Secondary Bile Duct Stones Harbor Distinct Biliary Microbial Composition and Metabolic Potential

Feng, R., Zhang, T., Kayani, M. U. R., Wang, Z., Shen, Y., Su, K. L., Bielike, K., & Chen, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.881489 · Cited by 22

Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis

Kim, Y.-H., Cho, N., & Kang, G. H. (2022) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2022.03.13 · Cited by 28

RASSF4 inhibits cell proliferation and increases drug sensitivity in colorectal cancer through YAP/Bcl‐2 pathway

Han, Y., Zhang, X., Guan, M., Huo, C., Yu, C., Hu, B., & Cai, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17395 · Cited by 21

Anti-tumor activity of polysaccharides extracted from Pinus massoniana pollen in colorectal cancer- in vitro and in vivo studies

Shang, H., Niu, X., Cui, W., Sha, Z., Wang, C., Huang, T., Guo, P., Wang, X., Gao, P., Zhang, S., et al. (2022) · Food & Function · doi:10.1039/d1fo03908c · Cited by 22

Fecal microbiome transplantation attenuates manganese-induced neurotoxicity through regulation of the apelin signaling pathway by inhibition of autophagy in mouse brain

Liu, J., Zhang, X., Ta, X., Luo, M., Chang, X., & Wang, H. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113925 · Cited by 24

Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings

Das, B. K. (2022) · Apmis · doi:10.1111/apm.13282 · Cited by 25

Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer

Kosumi, K., Baba, Y., Yamamura, K., Nomoto, D., Okadome, K., Yagi, T., Toihata, T., Kiyozumi, Y., Harada, K., Eto, K., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02112-x · Cited by 21

Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing

Welham, Z., Li, J., Engel, A. F., & Molloy, M. P. (2023) · Cancers · doi:10.3390/cancers15205045 · Cited by 23

From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential

Mignini, I., Piccirilli, G., Galasso, L., Termite, F., Esposto, G., Ainora, M. E., Gasbarrini, A., & Zocco, M. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020420 · Cited by 25

Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy

Fiedler, E. C., & Hemann, M. T. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055524 · Cited by 22

FusoPortal: an Interactive Repository of Hybrid MinION-Sequenced Fusobacterium Genomes Improves Gene Identification and Characterization

Sanders, B. E., Umaña, A., Lemkul, J. A., & Slade, D. J. (2018) · mSphere · doi:10.1128/msphere.00228-18 · Cited by 22

Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-Augmented Clinical Trials

Park, R., Umar, S., & Kasi, A. (2020) · Current Colorectal Cancer Reports · doi:10.1007/s11888-020-00456-1 · Cited by 21

CXXC5 orchestrates Stat3/Erk/Akt signaling networks to modulate P. gingivalis-elicited autophagy in cementoblasts

Ma, L., Liu, H., Wang, X., Jiang, C., Yao, S., Guo, Y., Wang, H., & Cao, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118923 · Cited by 23

The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy

Madkour, M. A., Altaf, R. A., Sayed, Z. S., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Mohamed, E. N., Toema, M., Wadan, A.-H. S., Nafady, M. H., et al. (2024) · Advanced Gut & Microbiome Research · doi:10.1155/2024/9919868 · Cited by 24

Interactions between the tumor microbiota and breast cancer

Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 22

Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis

Qin, W., Wang, S., Min, Y., Liu, X., Fang, J., Lang, J., & Chen, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03599-1 · Cited by 23

Harnessing the microbiome for cancer therapy

Hajjar, R., Mars, R. A. T., & Kashyap, P. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01268-6 · Cited by 29

GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer

Ma, R., Li, X., Liu, H., Jiang, R., Yang, M., Zhang, M., Wang, Y., Zhao, Y., & Li, H. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1599665 · Cited by 22

Fusobacterium�nucleatum‑positive colorectal cancer (Review)

Yang, Z., & Ji, G. (2019) · Oncology Letters · doi:10.3892/ol.2019.10433 · Cited by 20

Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX

Li, J., Li, J., Lyu, N., Ma, Y., Liu, F., Feng, Y., Li, Y., Hou, Z., Song, X., Zhao, H.-C., et al. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320904293 · Cited by 23

Intervention on gut microbiota may change the strategy for management of colorectal cancer

Taghinezhad‐S, S., Mohseni, A. H., & Fu, X. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15369 · Cited by 22

Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers

Kouzu, K., Tsujimoto, H., Kishi, Y., Ueno, H., & Shinomiya, N. (2021) · Medicines · doi:10.3390/medicines8080045 · Cited by 22

Let-7i-5p promotes a malignant phenotype in nasopharyngeal carcinoma via inhibiting tumor-suppressive autophagy

You, B., Zhang, P., Gu, M., Yin, H., Fan, Y., Yao, H., Pan, S. Y., Xie, H., Cheng, T., Liu, H., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.019 · Cited by 21

Novel microbiome signatures for non‐invasive diagnosis of adenoma recurrence after colonoscopic polypectomy

Liang, Q., Zeng, Y., Kwok, G., Cheung, C. P., Suen, B. Y., Ching, J. Y., To, K. F., Yu, J., Chan, F. K. L., & Ng, S. C. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16799 · Cited by 20

Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2‐Mediated Autophagy

Chang, S., Wu, J., Jin, J., Shi, H., Gao, R., Li, X., Jia, D., Sun, X., Ou, T., Yang, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2555476 · Cited by 23

Subversion of the Oral Microbiota and Induction of Immune-Mediated Systemic Inflammation with Special Reference to Periodontitis: Current Knowledge and Perspectives

Santacroce, L., Muzio, E. L., Bottalico, L., Spirito, F., Charitos, I. A., Passarelli, P. C., & Jirillo, E. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220629101357 · Cited by 22

The intestinal microbiota in colorectal cancer metastasis – Passive observer or key player?

Patel, M., McAllister, M. J., Nagaraju, R. T., Al-Badran, S. S. F., Edwards, J., McBain, A. J., Barriuso, J., & Aziz, O. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103856 · Cited by 21

Gut microbiota display alternative profiles in patients with early-onset colorectal cancer

Xiong, H., Wang, J., Chang, Z., Hu, H., Yuan, Z., Zhu, Y., Hu, Z., Wang, C., Liu, Y., Wang, Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1036946 · Cited by 23

Dysbiosis: The first hit for digestive system cancer

Mei, S., Deng, Z., Chen, Y., Ning, D.-M., Guo, Y., Fan, X., Wang, R., Meng, Y., Zhou, Q., & Tian, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1040991 · Cited by 22

Impact of microbiota on breast cancer hormone therapy

Terrisse, S. A., Zitvogel, L., & Kroemer, G. (2023) · Cell Stress · doi:10.15698/cst2023.03.277 · Cited by 22

Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignancies

Qing, Y., Guo, Y., Zhao, Q.-W., Hu, P., Li, H., Yu, X., Zhu, M., Wang, H., Wang, Z., Xu, J., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1229 · Cited by 21

Targeting Fusobacterium nucleatum through chemical modifications of host-derived transfer RNA fragments

Yang, M., Dong, P., Cen, L., Shi, W., He, X., & Li, J. (2023) · The ISME Journal · doi:10.1038/s41396-023-01398-w · Cited by 22

Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum , fecal occult blood, transferrin, CEA , CA19 ‐9, gender, and age

Zhao, R., Xia, D., Chen, Y., Kai, Z., Ruan, F., Xia, C., Gong, J., Wu, J., & Wang, X. (2023) · Cancer Medicine · doi:10.1002/cam4.6067 · Cited by 22

Herbal medicine and its impact on the gut microbiota in colorectal cancer

Bu, F., Tu, Y., Wan, Z., & Tu, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1096008 · Cited by 23

Hypoxia-Directed and Self-Immolative Theranostic Agent: Imaging and Treatment of Cancer and Bacterial Infections

Karan, S., Cho, M. Y., Lee, H.-S., Kim, H. M., Park, H. S., Han, E. H., Sessler, J. L., & Hong, K. S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01274 · Cited by 21

Prognostic impact of oral microbiome on survival of malignancies: a systematic review and meta-analysis

Li, S., Wang, T., Ren, Y., Liu, Z., Gao, J., & Guo, Z. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02419-7 · Cited by 23

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review

Saha, S., Ghosh, S., Ghosh, S., Nandi, S., & Nayak, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113325 · Cited by 25

TLR4 Targeting: A Promising Therapeutic Approach Across Multiple Human Diseases

Kumar, S., Sharma, V., & Yadav, S. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037324425241018061548 · Cited by 21

Human Intestinal Microbiota and Colorectal Cancer: Moving Beyond Associative Studies

Jobin, C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.030 · Cited by 21

Structure of the LPS O-chain from Fusobacterium nucleatum strain ATCC 23726 containing a novel 5,7-diamino-3,5,7,9-tetradeoxy-l-gluco-non-2-ulosonic acid presumably having the d-glycero-l-gluco configuration

VINOGRADOV, E. V., Michael, F. S., & Cox, A. D. (2018) · Carbohydrate Research · doi:10.1016/j.carres.2018.08.011 · Cited by 21

Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study

Guenther, M., Haas, M., Heinemann, V., Krüger, S., Westphalen, C. B., von Bergwelt‐Baildon, M., Mayerle, J. V., Werner, J., Kirchner, T., Boeck, S. H., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01029-7 · Cited by 22

Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform

Wei, P., Hung, C.-S., Kao, Y., Lin, Y., Lee, C., Chang, T., Shia, B., & Lin, J.-C. (2020) · Genes · doi:10.3390/genes11111374 · Cited by 21

Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression

Gao, Z., Li, Z., Liu, Y., & Liu, Z. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.554 · Cited by 21

Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma

Liu, L., Liang, L., Luo, Y., Han, J., Lu, D., Cai, R., Sethi, G., & Mai, S. (2024) · Research · doi:10.34133/research.0529 · Cited by 22

Intratumor microbiome-derived butyrate promotes chemo-resistance in colorectal cancer

Xu, L., Hu, B., He, J., Fu, X., & Liu, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1510851 · Cited by 22

Biomimetic “Trojan Horse” nanoparticles with biotactic behavior toward tumor-associated bacteria for targeted therapy of colorectal cancer

Wu, W., Guo, F., Wang, C., Qu, X., Wang, Q., Yang, Y. P., Yang, Y., & Ma, Y. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100092 · Cited by 22

Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease

Theis, B. F., Park, J. S., Kim, J. S., Zeydabadinejad, S., Vijay–Kumar, M., Yeoh, B. S., & Saha, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061357 · Cited by 24

The Influence of Caerulomycin A on the Intestinal Microbiota in SD Rats

Zhang, H., Lan, M., Cui, G., & Zhu, W. (2020) · Marine Drugs · doi:10.3390/md18050277 · Cited by 20

Zymosan promotes proliferation, Candida albicans adhesion and IL-1β production of oral squamous cell carcinoma in vitro

Chen, X., Luo, Q., Ding, J., Yang, M., Zhang, R., & Chen, F. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00315-6 · Cited by 20

The Dynamic Changes of Gut Microbiota during the Perinatal Period in Sows

Lan, S., Zhang, Y., Chen, W., Lan, T., Wang, Y., Wu, Y., Liao, X., & Mi, J. (2020) · Animals · doi:10.3390/ani10122254 · Cited by 20

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes

Huang, Q., Yao, F., Zhou, C., Huang, X., Wang, Q., Long, H., & Wu, Q. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i24.6213 · Cited by 21

Periodontal Pathogens Promote Foam Cell Formation by Blocking Lipid Efflux

Rho, J. H., Kim, H. J., Joo, J., Lee, J. Y., Lee, J. H., & Park, H. R. (2021) · Journal of Dental Research · doi:10.1177/00220345211008811 · Cited by 20

Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU

Wang, Z., Hopson, L. M., Singleton, S. S., Yang, X., Jogunoori, W. S., Mazumder, R., Obias, V., Lin, P., Nguyen, B.-N. H., Yao, M. D., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166179 · Cited by 20

Lactiplantibacillus plantarum HNU082 inhibited the growth of Fusobacterium nucleatum and alleviated the inflammatory response introduced by F. nucleatum invasion

Wang, Y., Li, J., Ma, C., Jiang, S., Li, C., Zhang, L., & Zhang, J. (2021) · Food & Function · doi:10.1039/d1fo01388b · Cited by 22

The Role of Gut Microbiota in Gastrointestinal Tract Cancers

Grochowska, M., Perlejewski, K., Laskus, T., & Radkowski, M. (2022) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-021-00641-6 · Cited by 20

A neural network‐based framework to understand the type 2 diabetes‐related alteration of the human gut microbiome

Guo, S., Zhang, H., Chu, Y., Jiang, Q., & Ma, Y. (2022) · iMeta · doi:10.1002/imt2.20 · Cited by 19

miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2

Song, Z., Liao, C., Yao, L., Xu, X., Shen, X., Tian, S., Wang, S., & Xing, F. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00574-y · Cited by 20

Cascade Catalytic Nanoparticles Selectively Alkalize Cancerous Lysosomes to Suppress Cancer Progression and Metastasis

Pan, L., Peng, H., Lee, B., Zhao, J., Shen, X., Yan, X., Hua, Y., Kim, J., Kim, D., Lin, M., et al. (2023) · Advanced Materials · doi:10.1002/adma.202305394 · Cited by 21

Role of the intratumoral microbiome in tumor progression and therapeutics implications

Meng, Y., Fan, Z., Zhou, B., & Zhan, H. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189014 · Cited by 20

Targeted elimination of Fusobacterium nucleatum alleviates periodontitis

Yakar, N., Ünlü, Ö., Cen, L., Hastürk, H., Chen, T., Shi, W., He, X., & Kantarcı, A. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2388900 · Cited by 20

Microbiota in tumors: new factor influencing cancer development

Jiang, H., Li, L., Bao, Y., Cao, X., & Ma, L. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00833-0 · Cited by 24

Changes in intestinal microbiota affect metabolism of ginsenoside Re

Zhang, L., Li, F., Qin, W., Fu, C., & Zhang, X. (2018) · Biomedical Chromatography · doi:10.1002/bmc.4284 · Cited by 20

Human omental adipose-derived mesenchymal stem cells enhance autophagy in ovarian carcinoma cells through the STAT3 signalling pathway

Chu, Y., Wang, Y., Li, K., Liu, M., Zhang, Y., Li, Y., Hu, X., Liu, C., Zhou, H., Zuo, J., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109549 · Cited by 19

The gut microbiome and potential implications for early-onset colorectal cancer

Mukherji, R., & Weinberg, B. A. (2020) · Colorectal Cancer · doi:10.2217/crc-2020-0007 · Cited by 21

Triclosan inhibits testosterone biosynthesis in adult rats via inducing m6A methylation-mediated autophagy

Sang, J., Ji, Z., Li, H., Wang, H., Quan, H., Yu, Y. W., Yan, J., Mao, Z., Wang, Y., Li, L., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108827 · Cited by 19

Progress of tumor-resident intracellular bacteria for cancer therapy

Bao, P., & Zhang, X. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115458 · Cited by 19

Gut microbiota in cancer initiation, development and therapy

Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19

Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment

Han, Q., Li, J., Li, Z. Y., Aishajiang, R., & Yu, D. N. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101601 · Cited by 23

Tissue-resident microbiota impacts colorectal cancer progression and prognosis

Shi, Z., Ren, H., Lin, C., Li, F., Wu, M., Yang, F., Luo, T., Nunes, L., Isaksson, A., Hammarström, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67047-2 · Cited by 24

Intervention strategies for microbial therapeutics in cancer immunotherapy

Gopalakrishnan, V., Weiner, B. J., Ford, C. B., Sellman, B. R., Hammond, S. A., Freeman, D. J., Dennis, P. A., Soria, J., Wortman, J. R., & Henn, M. R. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.05.001 · Cited by 20

Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection

Lin, R., Han, C., Ding, Z., Shi, H., He, R., Liu, J., Qian, W., Zhang, Q., Fu, X., Deng, X., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.032 · Cited by 19

LncRNA FTX promotes the malignant progression of colorectal cancer by regulating the miR-214-5p–JAG1 axis

Pan, L., Du, M., Liu, H., Cheng, B., Zhu, M., Jia, B., Wang, Y., He, W., Li, X., Liu, C., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2755 · Cited by 19

Pan-Cancer Analysis of Prognostic and Immune Infiltrates for CXCs

Long, L., Yao, W., Yan, S. R., Dong, X., Lv, Z., Jing, Q., Wang, Q., Ma, B., Hao, C., Xue, D., et al. (2021) · Cancers · doi:10.3390/cancers13164153 · Cited by 19

Role of Maternal Infections and Inflammatory Responses on Craniofacial Development

Bhagirath, A. Y., Medapati, M. R., de Jesus, V. C., Yadav, S., Hinton, M., Dakshinamurti, S., & Atukorallaya, D. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.735634 · Cited by 20

Simple and effective bacterial-based intratumoral cancer immunotherapy

Carroll, C., Andrew, E. R., Malik, L., Elliott, K. F., Brennan, M., Meyer, J., Hintze, A., Almonte, A. A., Lappin, C., Macpherson, P., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002688 · Cited by 20

Bifidobacterium infantis Maintains Genome Stability in Ulcerative Colitis via Regulating Anaphase-Promoting Complex Subunit 7

Han, T., Hu, X., Li, K., Zhang, D., Zhang, Y., & Li, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.761113 · Cited by 19

The differences between fecal microbiota and intestinal fluid microbiota in colon polyps

Zhou, X., Zhang, S., Liu, D., Qian, H., Zhang, D., & Liu, Q. (2021) · Medicine · doi:10.1097/md.0000000000028028 · Cited by 22

The Implication of Gastric Microbiome in the Treatment of Gastric Cancer

Pappas‐Gogos, G., Tepelenis, K., Fousekis, F., Katsanos, K. H., Pitiakoudis, M. S., & Vlachos, K. (2022) · Cancers · doi:10.3390/cancers14082039 · Cited by 20

Gut microbiota: a potential target for improved cancer therapy

Zhao, M., Jiang, G., Zhou, H., Li, J., Xiang, W., Li, S., Wang, H., & Zhou, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04546-5 · Cited by 19

Fusobacterium nucleatum Promotes Autophagy-Mediated Chemoresistance

(2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2017-147 · Cited by 1

Drugs, Bugs, and Cancer: Fusobacterium nucleatum Promotes Chemoresistance in Colorectal Cancer

Ramos, A., & Hemann, M. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.018 · Cited by 87

The connection between Fusobacterium nucleatum levels and chemoresistance in colorectal cancer – a systematic review

Kalali, D., Tzalili, V., & Anestakis, D. (2024) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5603/njo.98314

Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway

Wang, N., Zhang, L., Leng, X.-X., Xie, Y., Kang, Z., Zhao, L., Song, L., Zhou, C., & Fang, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2333790 · Cited by 126

Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway

Lu, P., Xu, M., Xiong, Z., Zhou, F., & Wang, L. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2